1.01
-0.05(-4.72%)
Currency In USD
| Previous Close | 1.06 |
| Open | 1.08 |
| Day High | 1.09 |
| Day Low | 1 |
| 52-Week High | 13.59 |
| 52-Week Low | 0.98 |
| Volume | 118,320 |
| Average Volume | 300,383 |
| Market Cap | 36.77M |
| PE | -1.84 |
| EPS | -0.55 |
| Moving Average 50 Days | 1.55 |
| Moving Average 200 Days | 3.26 |
| Change | -0.05 |
FibroBiologics Files Patent For Novel Approach to Modulate Mitochondrial Activity Using Fibroblast-based Therapeutics
GlobeNewswire Inc.
Mar 04, 2025 1:30 PM GMT
This innovative method has the potential to unlock new treatment options for chronic conditions driven by mitochondrial dysregulation. HOUSTON, March 04, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics”) , a clinical-s
FibroBiologics and Charles River Announce Completion and Release of CYWC628 Master Cell Bank for the Manufacturing of Fibroblast Cell-based Wound Healing Therapeutic
GlobeNewswire Inc.
Feb 27, 2025 1:30 PM GMT
Master cell bank to be used in manufacturing of CYWC628 drug product to support upcoming clinical trial for diabetic foot ulcersHOUSTON, Feb. 27, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc., (Nasdaq: FBLG) ("FibroBiologics") and Charles River Lab
FibroBiologics to Host In-Person Analyst Day to Provide Research & Development Updates
GlobeNewswire Inc.
Feb 05, 2025 2:15 PM GMT
FibroBiologics to also present at the BIO CEO & Investor ConferenceHOUSTON, Feb. 05, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics”), a clinical-stage biotechnology company with 160+ patents issued and pending with a
If you invested $1000 in FibroBiologics, Inc. Common Stock (FBLG) since IPO date, it would be worth $57.71 as of March 14, 2025 at a share price of $1.01. Whereas If you bought $1000 worth of FibroBiologics, Inc. Common Stock (FBLG) shares 6 months ago, it would be worth $310.77 as of March 14, 2025 at a share price of $1.01.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.